Effect of Polytyrosine on the Hydrophobicity of Hydroxyethyl Starch Microspheres

References

• Spenlehauer G., Vert M., Benoit J. P., Boddaert A. In vitro and in vivo degradation of poly(D, L-lactide/glycolide) type microspheres made by solvent evaporation method. Biomaterials 1989; 10: 557–563
   PubMed Web of Science ®Google Scholar
• Gupta P. K., Mehta R. C., Douglas R. H., DeLuca P. P. In vivo evaluation of biodegradable progesterone micro-spheres in mares. Pharm. Res. 1992; 9: 1502
   PubMed Web of Science ®Google Scholar
• Hora M. S., Rana R. K., Nunberg J. H., Tice T. R., Gilley R. M., Hudson M. E. Release of human serum albumin from poly(lactide-co-glycolide) microspheres. Pharm. Res. 1990; 7: 1190–1194
   PubMed Web of Science ®Google Scholar
• Jeffrey H., Davis S. S. D. T., O'Hagan. The preparation and characterization of poly(lactide-co-glycolide) micro-particles. II. The entrapment of a model protein using a (water-in-oil)-in-water emulsion solvent evaporation technique. Pharm. Res. 1993; 10: 362–368
   PubMed Web of Science ®Google Scholar
• Sato T., Schroeder H. G., Kanke M., DeLuca P. P. Porous biodegradable microspheres for controlled drug delivery. I. Assessment of processing conditions and solvent removal techniques. Pharm. Res. 1988; 5: 21–30
   PubMed Web of Science ®Google Scholar
• Wang H., Schmitt E., Flanagan D. R., Linhardt R. J. Influence of formulation method on the in-vitro controlled release of protein from poly(ester) microspheres. J. Cont. Rel. 1991; 17: 23–31
   Web of Science ®Google Scholar
• Sansdrap P., Moes A. J. Influence of manufacturing parameters on the size characteristics and release profiles of nifedipine from poly(DL-lactide-co-glycolide) micro-spheres. Int. J. Pharm. 1993; 98: 157–164
   Web of Science ®Google Scholar
• Artursson P., Edman P., Laakso T., Sjoholm I. Characterization of polyacryl starch microparticles as carriers for proteins and drugs. J. Pharm. Sci. 1984; 12: 1507–1513
   Google Scholar
• DeLuca P. P., Rypacek F. Biodegradable micro-spheres as carriers for macromolecules. May 3, 1988, U.S. patent 4,741,872
   Google Scholar
• O'Hagan D. T. Intestinal translocation of particulates-Implications for drug and antigen delivery. Adv. Drug Del. 1990; 5: 265–285
   Google Scholar
• Mestecky J., Moldoveanu Z., Novak M., Huang W. Q., Gilley R. M., Staas J. K., Schafer D., Compans R. W. Biodegradable microspheres for the delivery of oral vaccines. J. Cont. Rel. 1994; 28: 131–141
   Web of Science ®Google Scholar
• Kreuter J., Liehl E., Berg U., Soliva M., Speiser P. P. Influence of hydrophobicity on the adjuvant effect of particulate polymeric adjuvants. Vaccine June, 1988; 6
   PubMed Web of Science ®Google Scholar
• Pappo J., Ermak T. H., Steger H. J. Monoclonal antibody directed targeting of fluorescent microspheres to Peyer's patch M cells. Immunology 1991; 73: 277–280
   PubMed Web of Science ®Google Scholar
• Jenkins P. G., Howard K. A., Blackhall N. W., Thomas N. W., Davis S. S. D. T., O'Hagan. Microparticulate absorption from the rat intestine. J. Cont. Rel. 1994; 29: 339–350
   Web of Science ®Google Scholar
• Rudt S., Muller R. H. In vitro phagocytosis assay of nano-and microparticles by chemiluminescence II. Effect of surface modification by coating of particles with poloxamer on the phagocytic uptake. J. Cont. Rel. 1993; 25: 51–59
   Web of Science ®Google Scholar
• Lee V. H.L. Peptide and protein drug delivery: Opportunities and challenges. Pharmacy International 1986; 7: 208–212
   Web of Science ®Google Scholar
• Lin S. Y., Tzan Y. L., Lee C. J., Weng C. N. Preparation of enteric coated microspheres of Mycoplasm hyponeumoniae vaccine with cellulose acetate phthalate: 1. Formation condition and micromeritic properties. J. Microenc. 1991; 8: 317–325
   PubMed Web of Science ®Google Scholar
• Lazzell V., Waldman R. H., Rose C., Khakoo R., Jackowitz A., Howard S. Immunization against influenza in humans using an oral enteric coated killed virus vaccine. Journal of Biological Standards 1984; 12: 315–321
   PubMedGoogle Scholar
• Staas J. K., Eldridge J. H., Morgan J. D., Finch O. B., Tice T. R., Gilley R. M. Microsphere vaccines: Enhanced immune response through adjuvant effect and multiple pulse release capability. Proceed. Intern. Symp. Control. Rel. Bioact. Mater. Controlled Release Society, Inc., 1991; 18: 619–620
   Google Scholar
• Eldridge J. H., Hammond C. J., Meulbroek J. A., Staas J. K., Gilley R. M., Tice T. R. Controlled vaccine release in the gut-associated lymphoid tissues. 1. Orally administered biodegradable microspheres target the Peyer's patches. J. Cont. Rel. 1990; 11: 205–214
   Web of Science ®Google Scholar
• Tabata Y., Ikada Y. Effect of surface wettability of microspheres on phagocytosis. J. Colloid Interface Sci. 1989; 127: 132–140
   Web of Science ®Google Scholar
• Tabata Y., Lonikar S. V., Horii F., Ikada Y. Immobilization of collagen onto polymer surfaces having hydroxyl groups. ACS Symp. Ser. 1980; 121
   Google Scholar
• Bowersock T. I., HogenEsch H., Suckow M., Porter R. E., Jackson R., Park H., Park K. Oral vaccination with alginate microsphere systems. J. Cont. Rel. 1996; 39: 209–220
   Web of Science ®Google Scholar
• Moghimi S. M., Muir I. S., Illum L., Davis S. S., Kolb-Bachofen V. Coating particles with block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum. Biochim. Biophys. Acta. 1993; 1157: 233–240
   PubMed Web of Science ®Google Scholar
• Huang L., Mehta R., DeLuca P. P. Development of a statistical model for the formation of poly [acryloyl hydroxyethyl starch] microspheres. Pharm. Res. 1997; 14(4)469–474
   PubMed Web of Science ®Google Scholar
• Martin A., Swarbrick J., Cammarata A. Interfacial Phenomena Physical PharmacyThird edition. Lea and Febiger. 1983; 465–466
   Google Scholar
• Buckton G. Contact angle, adsorption and wettability-A review with respect to powders. Pow. Tech. 1990; 61: 237–249
   Web of Science ®Google Scholar